Jane Street’s RAPT Therapeutics RAPT Stock Holding History

Jane Street’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,688	Closed	-$2.29M	–	10313
2022 Q2	$2.29M	Buy	+15,688	New	+$2.09M	﹤0.01%	3907
2021 Q4	–	Sell	-2,563	Closed	-$637K	–	10687
2021 Q3	$637K	Sell	2,563 -3,050	-54%	-$806K	﹤0.01%	6820
2021 Q2	$1.43M	Buy	+5,613	New	+$1.05M	﹤0.01%	5037

Jane Street's RAPT Position: Q1 2026 in Review

Jane Street sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 84,778 shares — an estimated $2.87M sold.

Jane Street first reported a position in RAPT in Q2 2020 and held it in 10 quarters. The position peaked at $2.87M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Jane Street reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Jane Street sold 84,778 RAPT Therapeutics shares in Q1 2026, an estimated $2.87M.
Jane Street first reported a position in RAPT Therapeutics in Q2 2020 and held it in 10 quarters.
Jane Street's RAPT Therapeutics position peaked at $2.87M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.